Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,095 USD | 0,00% | 0,00% | -5,09% |
Vakgebied
Aantal werknemers: 13
Verkoop per activiteit
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Life Science Technologies
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +11,04% |
Verkoop per regio
USD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +11,04% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Barthel
CEO | Chief Executive Officer | - | 16-11-21 |
George Kovalyov
DFI | Director of Finance/CFO | 39 | 21-12-21 |
Chairman | 70 | 22-02-21 | |
Donald Very
CTO | Chief Tech/Sci/R&D Officer | 66 | 02-12-20 |
Catherine Pachuk
CTO | Chief Tech/Sci/R&D Officer | 67 | 31-07-20 |
Navdeep Cheema
LAW | General Counsel | - | - |
Amar Dhaduk
PRN | Corporate Officer/Principal | - | - |
Harrison Ross
PRN | Corporate Officer/Principal | 33 | 23-12-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Michael Stewart
BRD | Director/Board Member | 66 | 01-06-22 |
David Barthel
CEO | Chief Executive Officer | - | 16-11-21 |
William G. Hearl
BRD | Director/Board Member | 66 | 30-10-20 |
Chairman | 70 | 22-02-21 | |
Terry Brostowin
BRD | Director/Board Member | 64 | 14-12-18 |
Nilesh Patel
BRD | Director/Board Member | 59 | 22-04-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 46 666 760 | 31 587 419 ( 67,69 %) | 0 | 67,69 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,09% | 4,43 mln. | |
-3,12% | 102 mld. | |
+1,47% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,71% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,50% | 16,36 mld. | |
+4,82% | 13,97 mld. | |
+32,32% | 12,17 mld. |
- Beurs
- Aandelen
- Koers GBSX
- Onderneming Marizyme, Inc.